![Scotland, UK. 30 May 2013. Lancet Journal report suggests that long term use of painkillers and nonsteroidal anti-inflammatory drugs such as Diclofenac could increase the risk of heart attacks or strokes. PLEASE Scotland, UK. 30 May 2013. Lancet Journal report suggests that long term use of painkillers and nonsteroidal anti-inflammatory drugs such as Diclofenac could increase the risk of heart attacks or strokes. PLEASE](https://c8.alamy.com/comp/D8J2PC/scotland-uk-30-may-2013-lancet-journal-report-suggests-that-long-term-D8J2PC.jpg)
Scotland, UK. 30 May 2013. Lancet Journal report suggests that long term use of painkillers and nonsteroidal anti-inflammatory drugs such as Diclofenac could increase the risk of heart attacks or strokes. PLEASE
![Long-term effect of diclofenac sodium on response of primary calvarial... | Download Scientific Diagram Long-term effect of diclofenac sodium on response of primary calvarial... | Download Scientific Diagram](https://www.researchgate.net/publication/264630314/figure/fig1/AS:601709118242819@1520470041239/Long-term-effect-of-diclofenac-sodium-on-response-of-primary-calvarial-osteoblasts-in.png)
Long-term effect of diclofenac sodium on response of primary calvarial... | Download Scientific Diagram
![Painkiller heart attack risk: Don't stop taking Diclofenac pills but talk to your GP | Daily Mail Online Painkiller heart attack risk: Don't stop taking Diclofenac pills but talk to your GP | Daily Mail Online](https://i.dailymail.co.uk/i/pix/2011/09/27/article-2042619-0E1E2D3200000578-354_1024x615_large.jpg)
Painkiller heart attack risk: Don't stop taking Diclofenac pills but talk to your GP | Daily Mail Online
![Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet](https://www.thelancet.com/cms/attachment/2000988127/2003634384/gr1.gif)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet
![Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases](https://pub.mdpi-res.com/cancers/cancers-14-04385/article_deploy/html/images/cancers-14-04385-g001.png?1662701546)
Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
![Molecules | Free Full-Text | Kinetic Model of Diclofenac Degradation Developed Using Multivariate Curve Resolution Method Molecules | Free Full-Text | Kinetic Model of Diclofenac Degradation Developed Using Multivariate Curve Resolution Method](https://pub.mdpi-res.com/molecules/molecules-27-07904/article_deploy/html/images/molecules-27-07904-ag.png?1669018522)